EDURANT (Janssen Products, LP)
Welcome to the PulseAid listing for the EDURANT drug offered from Janssen Products, LP. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Non-Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Products, LP |
| NON-PROPRIETARY NAME: | rilpivirine hydrochloride |
| SUBSTANCE NAME: | RILPIVIRINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Non-Nucleoside Analog [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-05-20 |
| END MARKETING DATE: | 0000-00-00 |
EDURANT HUMAN PRESCRIPTION DRUG Details:
| Item Description | EDURANT from Janssen Products, LP |
| LABELER NAME: | Janssen Products, LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2011-05-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59676-278_cb979e5d-5aac-43ee-8216-7dd42be420ad |
| PRODUCT NDC: | 59676-278 |
| APPLICATION NUMBER: | NDA202022 |
Other RILPIVIRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
